Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4370-4373

  Bowker, Karen E ^a   Noel, Alan R ^a   MacGowan, Alasdair P ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE; RIFAMPICIN; VANCOMYCIN;

ADD ON THERAPY; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG HALF LIFE; IN VITRO STUDY; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; RIFAMPIN; VANCOMYCIN;

EID: 57049112848     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00922-07     Document Type: Article

References (15)

1. Agwuh, K. N., and A. P. MacGowan. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother. 58:256-265.
2. Andrews, J. M. 1999. Microbiological assays, p. 45-64. In D. S. Reeves, R. Wise, J. M. Andrews, and L. O. White (ed.), Clinical antimicrobial assays. Oxford University Press, Oxford, United Kingdom.
3. Blaser, J., B. B. Stone, and S. H. Zinner. 1985. Two compartment kinetic model with multiple artificial capillary units. J. Antimicrob. Chemother. 15(Suppl. A):131-137.
4. Bouchillon, S., T. Stevens, J. Johnson, D. Hoban, B. Johnson, R. Badal, and M. Dowzicky. 2006. In vitro activity of tigecycline against pathogens from Switzerland, Sweden, and Netherlands-T.E.S.T. Program 2006, abstr. E-733, p.184. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
5. Christiansson, J., D. Andes, and W. Craig. 2001. Characterization of the pharmacodynamics of doxycycline against Streptococcus pneumoniae in a murine thigh-infection model, abstr. A-1103, p.27. Abstr. 41th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
6. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic indices: rationale for antimicrobial dosing of mice and men. Clin. Infect. Dis. 26:1-10.
7. Cunha, B. A., P. Domenica, and C. B. Cunah. 2000. Pharmacodynamics of doxycycline. Clin. Microbiol. Infect. 6:270-273.
8. Gemmell, C. G., D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgeway, and R. E. Warren on behalf of the Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association. 2006. Guidelines for the prophylaxis and treatment of methicillin resistant Staphylococcus aureus (MRSA) infections in the UK. J. Antimicrob. Chemother. 57:589-608.
9. Jenner, P. 1999. Antimicrobial drugs, p. 205-219. In D. S. Reeves, R. Wise, J. M. Andrews, and L. O. White (ed.), Clinical antimicrobial assays. Oxford University Press, Oxford, United Kingdom.
10. Meagher, A. K., J. A. Passarell, B. B. Cirinione, S. A. Van Wart, K. Liolios, T. Babichak, E. J. Ellis-Grose, and P. G. Ambrose. 2007. Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections. Antimicrob. Agents Chemother. 51:1939-1945.
11. Muder, R., M. Boldin, C. Brennen, M. Hsieh, R. M. Vickers, K. Mitchum, and Y. C. Lee. A controlled trial of rifampicin, minocycline and rifampicin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long-term patients. J. Antimicrob. Chemother. 34:188-190.
12. Nicolau, D. P., C. D. Freeman, C. H. Nightingale, C. J. Coe, and R. Quintililani. 1994. Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38:1515-1518.
13. Petersen, P. J., P. Labthavikul, C. H. Jones, and P. A. Bradford. 2006. In vitro activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother. 57:573-576.
14. van Ogtrop, M. L., D. Andes, T. J. Stamstad, B. Conklin, W. J. Weiss, W. A. Craig, and O. Vesga. 2000. In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY152,288) against various gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 44:943-949.
15. Yin, L., L. Lazzarini, F. Li, C. M. Stevens, and J. H. Calhoun. 2005. Comparative evaluation of tigecycline and vancomycin with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J. Antimicrob. Chemother. 55:995-1002.